Pulmonary Adaptive Responses to HIIT in COPD
COPDEX0
1 other identifier
interventional
24
1 country
2
Brief Summary
Patients with chronic obstructive lung disease (COPD) suffer from a progressive loss of lung function that leads to poor quality of life, and often invalidity and early death. Regular exercise can improve quality of life in these patients, but the health care system lack the underlying mechanism of exercise-induced improvement in COPD and it is widely thought not to have any effect on lung function. The aim of the present study is to investigate to which extent lung tissue mass and rest-to-exercise diffusion capacity changes differ in COPD patients compared to the healthy state. In order to design prospective clinical trials on the putative impact of high-intensity interval training (HIIT) investigating these parameters, and a secondary aim is to assess the feasibility of such a study in terms of patient inclusion, adherence and methodology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Sep 2022
Typical duration for not_applicable chronic-obstructive-pulmonary-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2022
CompletedFirst Submitted
Initial submission to the registry
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedOctober 17, 2022
October 1, 2022
1.9 years
September 13, 2022
October 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lung tissue mass
Change in lung weight in COPD patients compared to matched controls using CT-scans.
CT-scans at baseline and at 12 week follow up.
Rest-to-exercise diffusion capacity
Change in rest-to-exercise pulmonary diffusion capacity between COPD patients and matched healthy controls measured by DLNO/CO.
DLNO/CO measured at baseline and at 12 week follow up.
Secondary Outcomes (2)
Rest-to-exercise pulmonary perfusion ratio change
At baseline and at 12 week follow up
Rest-to-exercise leg blood flow change in COPD
At baseline and at 12 week follow up
Other Outcomes (38)
Rest-to-exercise cardiac output change
At baseline and at 12 week follow up
VO2peak (and estimated VO2max)
At baseline and at 12 week follow up
VO2 verification bout
At baseline and at 12 week follow up
- +35 more other outcomes
Study Arms (2)
COPD patients
EXPERIMENTALThis arm will consist of only COPD patients.
Healthy controls
EXPERIMENTALThis arm will consist of age and BMI matched healthy controls.
Interventions
Participants will undergo 12 weeks of supervised HIIT training (3 times per week). The HIIT protocol will consist of 4x4 min.
Eligibility Criteria
You may qualify if:
- Men and women
- years
- COPD (GOLD stage I to III)
- Forced expiratory volume in 1 sec (FEV1)/forced vital capacity ratio (FVC) \< 0.8, FEV1 \< 90% of predicted value
- Modified Medical Research Council score (mMRC 0 - 3)
- Resting arterial oxygenation \> 90%
- Do not fulfil the physical activity recommendations by the Danish Health Authority
- Men and women
- years
- Normal FEV1, FVC, FEV1/FVC, and single-breath diffusion capacity
- Same sex, age (± 3 years) and BMI (± 10%)
- Do not fulfil the physical activity recommendations by the Danish Health Authority (19)
- BMI 18-35
You may not qualify if:
- Symptoms of ischaemic heart disease
- Known heart failure
- Previous severe or current COVID-19
- Unable to complete or understand HIIT training
- Claudication
- Symptoms of disease within 2 weeks prior to the study
- Participation in pulmonary rehabilitation within 6 months
- Known malignant disease
- Pregnancy
- Unstable cardiac arrhythmic disease
- Renal or liver dysfunction
- COPD
- Asthma
- Known ischaemic heart disease
- Known heart failure
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre for Physical Activity Research (CFAS)
Copenhagen, 2100, Denmark
Rigshospitalet
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, DMSc, Associate Professor, Principal investigator
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 23, 2022
Study Start
September 5, 2022
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
October 17, 2022
Record last verified: 2022-10